arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2105.01249physics.med-ph
收藏

剪切激活纳米粒靶向给药治疗主动脉疾病的数学模型

Mathematical modeling of shear-activated targeted nanoparticle drug delivery for the treatment of aortic diseases

Yonghui Qiao, Yan Wang, Yanlu Chen, Kun Luo, Jianren Fan

摘要:

人体主动脉是血管疾病的高风险区域,通常通过胸主动脉腔内修复术进行修复。在本文中,我们报告了一个有前途的剪切激活靶向纳米颗粒药物输送策略,以协助治疗主动脉缩窄和主动脉瘤。分别设计了主动脉缩窄和主动脉瘤的理想三维几何模型。患病主动脉的独特血液动力学环境用于改善纳米颗粒药物递送。纳米药物微载体通过局部异常剪切应力率(SSR)靶向激活释放纳米药物。主动脉缩窄提供高SSR血流动力学环境,而主动脉瘤暴露于低SSR。我们提出了一种方法来计算SSR阈值的患病主动脉。结果表明,病变部位的上游近壁区域是微载体的理想注射位置,异常SSR可以激活微载体。释放的纳米颗粒药物将被成功地靶向递送到主动脉病变壁。此外,微载体和纳米颗粒药物的高扩散性对患病主动脉壁的表面药物浓度具有显著影响,特别是对于主动脉瘤。本研究初步论证了剪切激活靶向纳米粒给药系统治疗主动脉疾病的可行性,为开发新的给药系统和新的治疗方法提供了理论依据。

英文摘要:

The human aorta is a high-risk area for vascular diseases, which are commonly restored by thoracic endovascular aortic repair. In this paper, we report a promising shear-activated targeted nanoparticle drug delivery strategy to assist in the treatment of coarctation of the aorta and aortic aneurysm. Idealized three-dimensional geometric models of coarctation of the aorta and aortic aneurysm are designed, respectively. The unique hemodynamic environment of the diseased aorta is used to improve nanoparticle drug delivery. Micro-carriers with nanoparticle drugs would be targeting activated to release nanoparticle drugs by local abnormal shear stress rate (SSR). Coarctation of the aorta provides a high SSR hemodynamic environment, while the aortic aneurysm is exposed to low SSR. We propose a method to calculate the SSR thresholds for the diseased aorta. Results show that the upstream near-wall area of the diseased location is an ideal injection location for the micro-carriers, which could be activated by the abnormal SSR. Released nanoparticle drugs would be successfully targeted delivered to the aortic diseased wall. Besides, the high diffusivity of the micro-carriers and nanoparticle drugs has a significant impact on the surface drug concentrations of the diseased aortic walls, especially for aortic aneurysms. This study preliminary demonstrates the feasibility of shear-activated targeted nanoparticle drug delivery in the treatment of aortic diseases and provides a theoretical basis for developing the drug delivery system and novel therapy.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑